Clinical Trial Update: Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TQB2102 to Trastuzumab Emtansine for HER2-positive metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TQB2102
• Trastuzumab emtansine (ado-trastuzumab emtansine)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Metastatic Breast Cancer | Phase 3 | Status: RECRUITING